CRIS Current Research Information System

BELLUTI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.858
EU - Europa 3.316
AS - Asia 1.690
AF - Africa 247
SA - Sud America 18
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.834
GB - Regno Unito 848
IT - Italia 726
CN - Cina 629
DE - Germania 462
VN - Vietnam 363
SE - Svezia 352
SG - Singapore 327
UA - Ucraina 236
IN - India 187
IE - Irlanda 131
FR - Francia 126
RU - Federazione Russa 126
JO - Giordania 90
ZA - Sudafrica 71
CI - Costa d'Avorio 70
TG - Togo 70
BG - Bulgaria 63
EE - Estonia 61
CH - Svizzera 31
IR - Iran 29
FI - Finlandia 24
CA - Canada 22
JP - Giappone 19
SC - Seychelles 19
BE - Belgio 18
CZ - Repubblica Ceca 16
GR - Grecia 16
HR - Croazia 16
ES - Italia 15
NL - Olanda 10
PL - Polonia 10
AT - Austria 8
BR - Brasile 8
NG - Nigeria 8
LB - Libano 7
PK - Pakistan 7
TR - Turchia 7
AU - Australia 6
ID - Indonesia 6
PT - Portogallo 6
EG - Egitto 5
HU - Ungheria 4
RO - Romania 4
AR - Argentina 3
BY - Bielorussia 3
CL - Cile 3
DZ - Algeria 3
EC - Ecuador 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IQ - Iraq 2
KR - Corea 2
KW - Kuwait 2
LK - Sri Lanka 2
MX - Messico 2
MY - Malesia 2
BD - Bangladesh 1
CO - Colombia 1
HK - Hong Kong 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
UZ - Uzbekistan 1
Totale 10.140
Salva come PNG Salva come JPEG
Città #
Southend 755
Fairfield 583
Chandler 560
Ashburn 440
Woodbridge 308
Seattle 274
Wilmington 273
Singapore 269
Houston 256
Bologna 252
Dong Ket 227
Cambridge 218
Ann Arbor 193
Princeton 188
Jacksonville 153
Dublin 131
Amman 90
New York 83
Westminster 81
Nanjing 80
Abidjan 70
Lomé 70
Padova 68
Berlin 64
Santa Clara 63
Sofia 63
Jinan 48
Bremen 46
San Diego 45
Saint Petersburg 43
Shenyang 40
Beijing 35
Redmond 35
Nanchang 32
Mülheim 31
Hebei 30
Bern 28
Milan 27
Dearborn 24
Tianjin 23
Helsinki 22
Jiaxing 22
Medford 21
Olalla 20
Shanghai 20
Boardman 18
Mahé 18
Brussels 17
Changsha 17
Des Moines 17
Redwood City 17
Tokyo 17
Venezia 16
Boydton 14
Mountain View 14
Guangzhou 13
Haikou 13
Zhengzhou 13
Los Angeles 12
Turin 12
Kunming 11
Fremont 10
Munich 10
Norwalk 10
Phoenix 10
Pune 10
Taiyuan 10
Verona 10
Brno 9
Urbino 9
Falls Church 8
Hangzhou 8
London 8
Ningbo 8
Shenzhen 8
Wuhan 8
Abeokuta 7
Casoria 7
Fuzhou 7
Lanzhou 7
San Jose 7
Asciano 6
Fidenza 6
Paris 6
Ravenna 6
Taizhou 6
Ancona 5
Antakya 5
Bühl 5
Forlì 5
Hyderabad 5
Jakarta 5
Madrid 5
Toronto 5
Vienna 5
Bentivoglio 4
Changzhou 4
Delhi 4
Elora 4
Ferrara 4
Totale 6.909
Salva come PNG Salva come JPEG
Nome #
1,4-dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety 264
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 218
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 189
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 175
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 163
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 155
Analogues of the dual acetylcholinesterase inhibitor AP2238: synthesis and SAR 148
Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold 146
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 145
Benzophenones as xanthone-open model CYP11B1 inhibitors potentially useful for promoting wound healing 145
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 143
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 142
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 142
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 138
Cardiovascular profile of xanthone-based 1,4 dihydropyridines bearing a lidoflazine pharmacophore fragment 138
Identification of chalcone-based antileishmanial agents targeting trypanothione reductase 132
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates 131
Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment? 131
Chitosan nanoparticles for curcumin delivery: development, characterization and in-vitro studies on cancer cells 130
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 128
Identification of a new tamoxifen-xanthene hybrid as pro-apoptotic anticancer agent 127
null 123
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach 123
Potent inhibition of human phosphodiesterase-5 by icariin derivatives 118
null 118
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 118
Potent inhibition of human phosphodiesterase-5 by icariin derivatives in an enzyme assay 112
Conjugation of Quinones with Natural Polyamines: Toward an Expanded Antitrypanosomatid Profile 112
Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment 111
Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors 110
Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. 109
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme 108
Homopterocarpanes as bridged triarylethylene analogues: synthesis and antagonistic effects in human MCF-7 breast cancer cells 108
Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment 108
Benzophenone derivatives as Inhibitors of Acetylcholinesterase 107
Multitarget Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania 106
null 105
New potent P-glycoprotein inhibitors carrying a polycyclic scaffold 104
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 104
Multi-target strategy to address Alzheimer’s disease: Design, synthesis and biological evaluation of new tacrine-based dimers 104
Multi-target-directed coumarin derivatives: hAChE and BAC1 inhibitors as potential anti-Alzheimer compounds 103
null 103
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 102
Curcumin-1,2,3-triazole conjugation for targeting the cancer apoptosis machinery. 102
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease 98
New derivatives of xanthenone-4-acetic acid: synthesis, pharmacological profile and effect on TNF-alpha and NO production by human immune cells 96
Design, Synthesis, and Biological and Crystallographic Evaluation of Novel Inhibitors ofPlasmodium falciparumEnoyl-ACP-reductase (PfFabI) 96
Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi 96
Hybrid drugs for Alzheimer's disease: new indanone derivatives bearing a pharmacophoric fragment of AP2238 95
High-throughput screening of beta-secretase inhibitors by multiwell FRET assay 95
Functionalization of the chalcone scaffold for the discovery of novel lead compounds targeting fungal infections 95
New Coumarin derivatives as cholinergic and cannabinoid system modulators 94
In vitro biological activity of new analogues of flavon-8-acetic acid 93
In vitro studies of flavon-8-acetic acid analogues 93
Nonsteroidal Aromatase inhibitors: synthesis and evaluation of new flavone derivatives 92
Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach 92
Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease 91
Targeting the Bacterial Membrane with a New Polycyclic Privileged Structure: A Powerful Tool To Face Staphylococcus aureus Infections 90
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation 88
Modulation of Cytochromes P450 with Xanthone-Based Molecules: From Aromatase to Aldosterone Synthase and Steroid 11β-Hydroxylase Inhibition 87
Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update. 87
Natural-like Chalcones with Antitumor Activity on Human MG63 Osteosarcoma Cells 87
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer 86
Studies on cytostatic and cytotoxic activity of new flavopiridol analogues 85
Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target 85
Progettazione e sintesi di derivati benzofuranici per la malattia di Alzheimer 84
The first dual ChE/FAAH inhibitors: new perspectives for Alzheimer's disease? 84
Curcumin derivatives as beta-secretase (BACE1) inhibitors. 84
null 83
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism 83
null 82
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 82
Mono- or di-fluorinated analogues of Flavone-8-acetic acid: synthesis and in vitro biological activity 80
Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm 80
null 79
Multifaceted activity of polyciclic MDR revertant agents in drug-resistant leukemic cells: Role of the spacer 78
null 76
Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012) 75
Imidazolylmethylxanthones as potent inhibitors of cytochrome P450 aromatase 75
Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation 75
null 73
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 70
null 70
null 67
New potent inhibitors of cytochrome P450 aromatase 66
In vitro methods for characterizing new multi-potent compounds for Alzheimer’s disease 65
null 64
Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells 63
Targeting neuronal calcium channels and GSK3β for Alzheimer's disease with naturally-inspired Diels-Alder adducts 61
null 58
Chalcone-based carbamates for Alzheimer's disease treatment 57
Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity 54
Tackling Alzheimer's Disease with Existing Drugs:A Promising Strategy for Bypassing Obstacles 52
Flavonoid-inspired vascular disrupting agents: Exploring flavone-8-acetic acid and derivatives in the new century 50
From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold 49
Prenylated Curcumin Analogues as Multipotent Tools to Tackle Alzheimer's Disease 49
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy 42
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold 42
Hitting drug-resistant malaria infection with triazole-linked flavonoid–chloroquine hybrid compounds 38
Quinone-Amino Acid Conjugates Targeting Leishmania Amino Acid Transporters 38
Totale 9.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.022
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.116 0 0 0 134 257 253 311 360 348 182 121 150
2020/20211.483 294 90 26 74 36 94 29 129 120 70 90 431
2021/20221.774 164 47 107 90 150 92 48 181 94 137 341 323
2022/20232.331 211 273 112 275 187 180 65 148 469 70 164 177
2023/2024745 40 99 38 89 54 212 47 42 14 35 38 37
2024/2025775 103 366 264 42 0 0 0 0 0 0 0 0
Totale 10.469